Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9227226 | Journal of Allergy and Clinical Immunology | 2005 | 8 Pages |
Abstract
Although small-molecule VLA-4 antagonists, such as WAY103, might reduce eosinophil adhesion, this approach might not be sufficient to eliminate this cell from in vivo allergic airway inflammatory participation and could even promote specific cell activation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Julie B. PhD, Kristyn J. PA, Jeffrey D. PhD, Hirohito MD, William W. MD,